logo
  

Sturm Ruger & Co Inc Q1 Income Retreats

Sturm Ruger & Co Inc (RGR) released a profit for first quarter that decreased from the same period last year

The company's earnings came in at $7.08 million, or $0.40 per share. This compares with $14.3 million, or $0.81 per share, in last year's first quarter.

The company's revenue for the quarter fell 8.4% to $136.8 million from $149.4 million last year.

Sturm Ruger & Co Inc earnings at a glance (GAAP) :

-Earnings (Q1): $7.08 Mln. vs. $14.3 Mln. last year.
-EPS (Q1): $0.40 vs. $0.81 last year.
-Revenue (Q1): $136.8 Mln vs. $149.4 Mln last year.

For comments and feedback contact: editorial@rttnews.com

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
RELATED NEWS
Follow RTT